Business Insights
Diagnostic Technologies
Diseases
Point-of-Care Testing
Research & Development
Sign In
Autoimmune
Cancer
Cardiovascular
COVID-19
Health Topics
Infectious
Cancer: Page 14
Danish National Genome Center selects Qiagen software for variant interpretation
By
LabPulse.com staff writers
The initiative is part of a larger personalized medicine strategy that aims to provide whole-genome sequencing as a standard-of-care for relevant patient groups in Denmark.
June 14, 2023
Machine learning models, blood biomarkers in research predict future disease risk
By
Nick Paul Taylor
Researchers found that analyzing genomic information and blood biomarkers is more accurate and cost-effective than analyzing genomic data alone.
June 12, 2023
Genetic counseling may boost colorectal cancer patient empowerment: Study
By
Elissa Wolfson
A randomized controlled genetic counseling trial for those affected by colorectal cancer showed significant improvements in patient empowerment.
June 12, 2023
Myriad Genetics, MD Anderson collaborate on metastatic renal cell carcinoma research
By
LabPulse.com staff writers
The project will use Myriad’s minimal residual disease testing platform, a tumor-informed high-definition assay that detects circulating tumor DNA.
June 12, 2023
Polygenic risk scores may improve colorectal cancer screening
By
Elissa Wolfson
Polygenic risk scores may identify individuals at high risk of developing colorectal cancer, improving current screening strategies for the disease.
June 12, 2023
PreCheck Health Services launches NGS cancer panel
By
LabPulse.com staff writers
The NGS assay will be available to the hospitals, oncologists, pathologists, clinics, and healthcare groups that PreCheck serves in southern Florida and beyond.
June 9, 2023
CAP, ASCO reduce confusion by reaffirming HER2 testing guidelines
By
LabPulse.com staff writers
The organizations reaffirmed the Human Epidermal Growth Factor Receptor 2 (HER2) Breast Cancer Testing Guidelines, reducing confusion over terminology for reporting HER2 results.
June 8, 2023
Burning Rock Biotech highlights breast cancer study using its genomic profiling test
By
LabPulse.com staff writers
In the study, OncoScreen Plus was used to determine activating mutations in PIK3CA and AKT1 and inactivating alterations in PTEN genes for patients in the trial who were enrolled in China.
June 8, 2023
Precipio prices $2M stock offering and concurrent private placement
By
LabPulse.com staff writers
The specialty cancer diagnostics company intends to use the net proceeds for working capital and general corporate purposes.
June 8, 2023
FDA clears DeepX Diagnostics digital dermatoscope to screen for suspected skin cancer lesions
By
LabPulse.com staff writers
The device has conducted more than 180 thousand assessments in pharmacies and primary care clinics in Europe; DeepX is poised to enter the U.S. market.
June 6, 2023
Dante Genomics introduces rare disease health package that leverages telemedicine, sequencing
By
LabPulse.com staff writers
The package includes telemedicine consultations with specialists who may not be available where a patient is located.
June 6, 2023
Low rates of genetic testing ‘a missed opportunity’ to reduce cancer burden
By
Nick Paul Taylor
The probability of a patient undergoing genetic testing increased over the course of the study, although male breast was the only indication that had a more than 50% likelihood of being tested at any time.
June 5, 2023
Previous Page
Page 14 of 100
Next Page